Blood retinal and blood aqueous barriers in diabetics by fluorophotometry
β Scribed by J. P. Boot; J. M. A. Gerven; J. A. Best; L. Vrij; H. H. P. J. Lemkes; J. A. Oosterhuis
- Publisher
- Springer-Verlag
- Year
- 1989
- Tongue
- English
- Weight
- 412 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0012-4486
No coin nor oath required. For personal study only.
β¦ Synopsis
The permeability of the blood retinal barrier (PBa~) and the diffusion coefficient into the anterior chamber (kd) in 20 insulin dependent (ID) and in 11 non-insulin dependent (NID) diabetics with various degrees of retinopathy were determined by fluorophotometry with a 25% accuracy. The difference of PBRB and the kd values between the NID and the ID patients was not significant (p > 0.05 and p > 0.22).
The mean P~rtB and the mean k d values differed significantly from those of a healthy population (p < 0.0013 and p = 0.025). A significant correlation was established between PBrt~ and diabetes duration (r = 0.55; p < 0.01) but not between PBRB or ka values and metabolic control (HbA1) (p > 0.5) or creatinine clearance (p > 0.5). The time integrals of unbound plasma fluorescein in the diabetics between the time of injection and 1 hour later were comparable with those of healthy controls.
The difference between the mean PBRB value of diabetics with advanced retinopathy and that of a healthy population was significant (p < 0.003) but the difference for the mean values of diabetics with no or minimal background retinopathy was not (p > 0.2), indicating that PBRB values do not increase to an abnormal level while signs of diabetic retinopathy are absent on fluorescein angiography.
π SIMILAR VOLUMES
The morphological base for the impaired function of the blood retinal barrier was studied in 50 eyes of 10 insulin dependent and 21 non-insulin dependent patients with various levels of diabetic retinopathy. The permeability of the blood retinal barrier (PBRB) was determined by vitreous fluorophotom
The effect of calcium dobesilate on the alteration of the blood-retinal barrier was studied in 41 adult-onset, non-insulin dependent diabetic patients with minimal or no retinopathy, randomly assigned to receive either oral calcium dobesilate (1000 mg twice daily) or a placebo for 12 months. The pos
Nineteen eyes with background sickle cell retinopathy, eleven from patients with SC disease, eight from patients with SS disease, and twelve eyes with proliferative sickle cell retinopathy were examined by direct and indirect ophthalmoscopy, slit-lamp, fluorescein angiography and vitreous fluorophot